ArticleFrontiers in oncology2025

Case Report: Dupilumab therapy for immune checkpoint inhibitor-induced bullous pemphigoid enables dual immunotherapy initiation in progressive malignant melanoma.

Janine Grüninger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.